Stock search

Ticker or company name

Compare stocks

Market: US

  • DXCMDexcom
  • LHLabcorp
  • DGXQuest Diagnostics

Add stock

Ticker or company

Summary

DXCM
Dexcom
$81,61Down −2,06%
Year: Up +40%
89/100Best scoreRatio would consider buying
Open stock page
LH
Labcorp
$372,46Up +0,53%
Year: Up +38%
56/100Ratio would watch
Open stock page
DGX
Quest Diagnostics
$262,21Up +1,01%
Year: Up +38%
61/100Ratio would watch
Open stock page

Verdict

DXCM has the best score (89). DXCM grows revenue the fastest. LH is the cheapest by forward P/E. DXCM has the lowest debt load. DXCM has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckDXCM8 ✓ 0 — 1 ✕LH3 ✓ 4 — 2 ✕DGX3 ✓ 5 — 1 ✕
P/E vs its history31,430,025,5
P/E vs industry31,430,025,5
Forward P/E26,818,621,3
Revenue growth, YoY+13,0%+6,0%+9,1%
EPS growth, YoY+41,1%+19,6%+17,8%
Net margin19,4%6,9%9,5%
Net debt / EBITDA−0,62,32,1
Free cash flow$1,10 bn$1,29 bn$1,38 bn
Share count over a year−5,9%−2,5%−0,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterDXCMTTMLHTTMDGXTTMIndustry medianTTM
P/E TTM ↓Worst: 31,430,0Best: 25,525,1
Forward P/E ↓Worst: 26,8Best: 18,621,316,2
PEG ↓Best: 1,4Worst: 3,22,62,2
P/S TTM ↓Worst: 6,1Best: 2,12,42,2
EV/EBITDA ↓Worst: 21,019,8Best: 17,917,3
P/FCF ↓Worst: 28,323,4Best: 20,919,5

Price, %

  • DXCMn/a
  • LHn/a
  • DGXn/a

Returns

Best WorstNo mark — in between

PeriodDXCMLHDGX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

DXCMLHDGX
Share of “buy”Best: 89%78%Worst: 52%
Beat the forecastWorst: 3 of 4Worst: 3 of 4Best: 4 of 4
Average “surprise”+0,9%Worst: +0,6%Best: +5,0%
Insiders over 12 monthssales $12,2 msales $11,7 msales $45,8 m

Details are on each stock page.